- Home
- SYRE vs BLFS Comparison
SYRE vs BLFS Comparison
Compare SYRE & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- BLFS
- Stock Information
- Founded
- SYRE 2013
- BLFS 1987
- Country
- SYRE United States
- BLFS United States
- Employees
- SYRE N/A
- BLFS N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- BLFS Medical/Dental Instruments
- Sector
- SYRE Health Care
- BLFS Health Care
- Exchange
- SYRE Nasdaq
- BLFS Nasdaq
- Market Cap
- SYRE 1.2B
- BLFS 1.2B
- IPO Year
- SYRE 2016
- BLFS 1989
- Fundamental
- Price
- SYRE $16.14
- BLFS $22.84
- Analyst Decision
- SYRE Strong Buy
- BLFS Strong Buy
- Analyst Count
- SYRE 8
- BLFS 8
- Target Price
- SYRE $51.50
- BLFS $29.50
- AVG Volume (30 Days)
- SYRE 661.8K
- BLFS 416.4K
- Earning Date
- SYRE 05-08-2025
- BLFS 03-03-2025
- Dividend Yield
- SYRE N/A
- BLFS N/A
- EPS Growth
- SYRE N/A
- BLFS N/A
- EPS
- SYRE N/A
- BLFS N/A
- Revenue
- SYRE N/A
- BLFS $82,254,000.00
- Revenue This Year
- SYRE N/A
- BLFS $20.68
- Revenue Next Year
- SYRE N/A
- BLFS $21.74
- P/E Ratio
- SYRE N/A
- BLFS N/A
- Revenue Growth
- SYRE N/A
- BLFS 8.44
- 52 Week Low
- SYRE $16.13
- BLFS $14.84
- 52 Week High
- SYRE $40.84
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- SYRE 35.24
- BLFS 36.48
- Support Level
- SYRE $16.71
- BLFS $25.03
- Resistance Level
- SYRE $18.28
- BLFS $26.30
- Average True Range (ATR)
- SYRE 1.21
- BLFS 1.37
- MACD
- SYRE -0.03
- BLFS -0.09
- Stochastic Oscillator
- SYRE 0.15
- BLFS 13.91
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.